Cardinal Health Cost of product sold — Goodwill, Impairment Loss remained flat by 0.0% to $90.00M in Q2 2024 compared to the prior quarter. Year-over-year, this metric declined by 75.3%, from $364.00M to $90.00M. Over 2 years (FY 2022 to FY 2024), Cost of product sold — Goodwill, Impairment Loss shows a downward trend with a -19.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase signals operational challenges or overpayment for past acquisitions, negatively impacting earnings.
This metric measures the reduction in the carrying value of goodwill assigned to the cost of product sold segment due to...
Standard impairment reporting across the healthcare wholesale industry.
cah_segment_cost_of_product_sold_goodwill_impairment_loss| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $525.00M | $525.00M | $525.00M | $525.00M | $154.00M | $709.00M | $0.00 | $364.00M | $581.00M | $585.00M | $90.00M | $90.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -70.7% | +360.4% | -100.0% | — | +59.6% | +0.7% | -84.6% | +0.0% |
| YoY Change | — | — | — | — | -70.7% | +35.0% | -100.0% | -30.7% | +277.3% | -17.5% | — | -75.3% |